MK
Manoj Kumar Tiwary
About Manoj Kumar Tiwary
Data last updated:
Manoj Kumar Tiwary is a Director at Stengen Pharma Private Limited (since 2025). The companies operate in Pharma. Earlier, Manoj Kumar Tiwary was a Director at Brochem Healthcare Private Limited (2009–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Stengen Pharma Private Limited U46497MH2025PTC445091 | Director | 08 Apr 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Brochem Healthcare Private Limited U24100MH2009PTC190719 | Director | 05 Mar 2009 | 2009 | ₹5.34 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manoj Kumar Tiwary
| Name | DIN | Company | Designation |
|---|---|---|---|
| Manoj Kumar Sinha | 11044824 | Stengen Pharma Private Limited | Director |
| Vinod Kumar | 11044825 | Stengen Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manoj Kumar Tiwary
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manoj Kumar Tiwary
Manoj Kumar Tiwary currently holds 1 directorship: Stengen Pharma Private Limited (Director, since 08 Apr 2025).
Manoj Kumar Tiwary was first appointed on 05 Mar 2009 as Director at Brochem Healthcare Private Limited. The most recent appointment on record is 08 Apr 2025 at Stengen Pharma Private Limited.
Manoj Kumar Tiwary held 1 earlier board appointment: Brochem Healthcare Private Limited (Director, 05 Mar 2009 to 24 Apr 2017).
The current boards of Manoj Kumar Tiwary's companies include Manoj Kumar Sinha (Stengen Pharma Private Limited), Vinod Kumar (Stengen Pharma Private Limited).